Publications

Explore publications relevant to our product candidates and technologies

OCS-01

blue ellipse
February 2023
|
ACTA OPHTHALMOLOGICA

Topical Treatment of Diabetic Macular Edema Using Dexamethasone Ophthalmic Suspension: A Randomized, Double-Masked, Vehicle-Controlled Study

EINAR STEFANSSON ET AL.
December 2022
|
CLINICAL THERAPY

OCS-01 (Novel Topical Dexamethasone Formulation) in Inflammation and Pain Post Cataract Surgery: A Randomized, Double-Masked, Vehicle-Controlled Study

MICHAEL KORENFELD ET AL.
October 2021
|
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE

Topical Dexamethasone-Cyclodextrin Microparticle Eye Drops For Diabetic Macular Edema

Masaki Tanito et al.
August 2015
|
ACTA OPHTHALMOLOGICA

Topical Dexamethasone-Cyclodextrin Nanoparticle Eye Drops for Non-Infectious Uveitic Macular Oedema and Vitritis – A Pilot Study

Shiri Shulman et al.
July 2015
|
ACTA OPHTHALMOLOGICA

Topical Dexamethasone γ-Cyclodextrin Nanoparticle Eye Drops Increase Visual Acuity and Decrease Macular Thickness in Diabetic Macular Oedema

Akihiro Ohira et al.

OCS-02

blue ellipse
July 2022
|
CLINICAL OPHTHALMOLOGY

Topical Anti-TNFα Agent Licaminlimab (OCS-02) Relieves Persistent Ocular Discomfort in Severe Dry Eye Disease: A Randomized Phase 2 Study

LEE SHETTLE ET AL.
June 2022
|
TRANSLATIONAL VISION, SCIENCE & TECHNOLOGY

Topical Ocular Anti-TNFα Agent Licaminlimab (OCS-02) in the Treatment of Acute Anterior Uveitis: A Randomized Phase 2 Pilot Study

THEODORE A. PASQUALI ET AL.

OCS-05

blue ellipse
March 2023
|
NATURE IN SCIENTIFIC REPORTS

A Phase 1 Randomized Study on The Safety and Pharmacokinetics of OCS-05, a Neuroprotective Disease Modifying Treatment for Acute Optic Neuritis and Multiple Sclerosis

PABLO VILLOSLADA ET AL.
July 2019
|
Neurotherapeutics

Axonal and Myelin Neuroprotection by The Peptoid BN201 in Brain Inflammation

Pablo Villoslada et al.

OPTIREACH

blue ellipse
March 2023
|
THE JOURNAL OF DRUG DELIVERY SCIENCE AND TECH

Topical Dexamethasone Delivery to The Retina: An Aqueous Cyclodextrin-Based Microsuspension

THORSTEINN LOFTSSON AND EINAR STEFANSSON
January 2022
|
EXPERT OPINION IN DRUG DELIVERY

Topical Drug Delivery to The Retina: Obstacles and Routes to Success

THORSTEINN LOFTSSON
June 2021
|
ACTA OPHTHALMOLOGICA

Angiotensin Receptor Blockers in Cyclodextrin Nanoparticle Eye Drops: Ocular Pharmacokinetics and Pharmacologic Effect on Intraocular Pressure

LAURA LORENZO-SOLER ET AL.
May 2021
|
PHARMACEUTICALS

Bio-Distribution and Pharmacokinetics of Topically Administered γ-Cyclodextrin Based Eye Drops in Rabbits

MARTIN KALLAB ET AL.
March 2021
|
INTERNATIONAL JOURNAL OF PHARMACOLOGY

Topical Drug Delivery to The Posterior Segment of The Eye: Thermodynamic Considerations

SUPPAKAN SRIPETCH AND THORSTEINN LOFTSSON

Our Potential to Transform Eye Care and Improve Patient Outcomes

Rethinking Ophthalmology